What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India

March 27, 2023 updated by: Esther Duflo, National Bureau of Economic Research, Inc.
COVID-19 poses a substantial risk to elderly populations; understanding how to get elders vaccinated against the virus is therefore a policy priority. An experiment with elders in Tamil Nadu, India will be used to evaluate interventions policymakers might use to raise vaccination rates amongst the elderly. The particular interventions being tested are: calling elders to inform them about vaccination; encouragement of a "buddy system," whereby elders are accompanied to the vaccination site by another adult who could also get the vaccine; and seeding vaccination information with "gossips," individuals who elders identify as being good at spreading information in the elders' communities. The interventions are phone-based, and can be implemented quickly and at low cost. This makes them promising strategies the Tamil Nadu government and other governments could use to vaccinate elderly populations against COVID-19.

Study Overview

Study Type

Interventional

Enrollment (Actual)

3006

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tamil Nadu
      • Chennai, Tamil Nadu, India
        • JPAL SA at IFMR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 55 years of age
  • Has phone number

Exclusion Criteria:

- Not part of the experiments registered under protocol IDs 223749 or 172020

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Community receives buddy and gossip treatment, individual informed directly (arm (1))

(i) Individual elder given vaccination information.

(ii) Individual elder encouraged to get vaccinated using "buddy system," whereby he/she is accompanied to the vaccination site by another adult who could also get the vaccine. A potential buddy also given vaccination information and encouraged to help the elder get to the vaccination site so they could both be vaccinated.

(iii) Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders and to encourage their communities to use the buddy system to get elders vaccinated.

Elder informed about vaccination.
Elder encouraged to get vaccinated using "buddy system," whereby he/she is accompanied to the vaccination site by another adult who could also get the vaccine. A potential buddy also given vaccination information and encouraged to help the elder get to the vaccination site so they could both be vaccinated.
Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders. If buddy intervention assigned in community, gossips also asked to encourage their communities to use the buddy system to get elders vaccinated.
Information intervention assigned for other elders in community.
Buddy intervention assigned for other elders in community.
Experimental: Community receives buddy and gossip treatment, individual not informed directly (arm (2))
Individual elder lives in community with elders in arm (1).
Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders. If buddy intervention assigned in community, gossips also asked to encourage their communities to use the buddy system to get elders vaccinated.
Information intervention assigned for other elders in community.
Buddy intervention assigned for other elders in community.
Experimental: Community receives gossip treatment, individual informed directly (arm (3))

(i) Individual elder given vaccination information.

(ii) Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders.

Elder informed about vaccination.
Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders. If buddy intervention assigned in community, gossips also asked to encourage their communities to use the buddy system to get elders vaccinated.
Information intervention assigned for other elders in community.
Experimental: Community receives gossip treatment, individual not informed directly (arm (4))
Individual elder lives in community with elders in arm (3).
Members of elder's community asked who in the community is good at spreading information. These "gossips" then asked to spread information about vaccination of elders. If buddy intervention assigned in community, gossips also asked to encourage their communities to use the buddy system to get elders vaccinated.
Information intervention assigned for other elders in community.
Experimental: Community receives buddy treatment, individual informed directly (arm (5))

(i) Individual elder given vaccination information.

(ii) Individual elder encouraged to get vaccinated using "buddy system," whereby he/she is accompanied to the vaccination site by another adult who could also get the vaccine. A potential buddy also given vaccination information and encouraged to help the elder get to the vaccination site so they could both be vaccinated.

Elder informed about vaccination.
Elder encouraged to get vaccinated using "buddy system," whereby he/she is accompanied to the vaccination site by another adult who could also get the vaccine. A potential buddy also given vaccination information and encouraged to help the elder get to the vaccination site so they could both be vaccinated.
Information intervention assigned for other elders in community.
Buddy intervention assigned for other elders in community.
Experimental: Community receives buddy treatment, individual not informed directly (arm (6))
Individual elder lives in community with elders in arm (5).
Information intervention assigned for other elders in community.
Buddy intervention assigned for other elders in community.
Experimental: Community receives information, individual informed directly (arm (7))
Individual elder given vaccination information.
Elder informed about vaccination.
Information intervention assigned for other elders in community.
Experimental: Community receives information, individual not informed directly (arm (8))
Individual elder lives in community with elders in arm (7).
Information intervention assigned for other elders in community.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Received at least one shot
Time Frame: 8 weeks after intervention
Elders asked on phone call if they have received zero, one, or two doses of COVID-19 vaccine. Outcome takes the value of 1 if they received at least one shot, and 0 otherwise.
8 weeks after intervention
Received two shots
Time Frame: 8 weeks after intervention
Elders asked on phone call if they have received zero, one, or two doses of COVID-19 vaccine. Outcome takes the value of 1 if they received two shots, and 0 otherwise.
8 weeks after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2021

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

April 28, 2021

First Submitted That Met QC Criteria

April 29, 2021

First Posted (Actual)

May 3, 2021

Study Record Updates

Last Update Posted (Actual)

March 29, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Information

3
Subscribe